Cathode Material Determines Product Selectivity for Electrochemical C−H Functionalization of Biaryl Ketoximes
作者:Huai‐Bo Zhao、Pin Xu、Jinshuai Song、Hai‐Chao Xu
DOI:10.1002/anie.201809679
日期:2018.11.12
N‐oxides has been developed through electrochemicalC−Hfunctionalization of biarylketoximes. The oxime substrates undergo dehydrogenative cyclization when a Pt cathode is used, resulting in unprecedented access to a wide range of N‐heteroaromatic N‐oxides. The products of the electrosynthesis are switched to the deoxygenated N‐heteroaromatics by employing a Pb cathode through sequential anode‐promoted
[EN] HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF CNS AND CARDIOVASCULAR DISORDERS<br/>[FR] COMPOSES HETEROCYCLIQUES POUR LE TRAITEMENT DES TROUBLES DU SYSTEME NERVEUX CENTRAL ET DES TROUBLES CARDIOVASCULAIRES
申请人:THE UPJOHN COMPANY
公开号:WO1995018118A1
公开(公告)日:1995-07-06
(EN) Novel aromatic bicyclic amines of formula (I) are useful in treating central nervous system disorders and cardiac arrhythmias and cardiac fibrillation.(FR) L'invention concerne de nouvelles amines bicycliques aromatiques de formule (I) destinées à être utilisées pour le traitement des troubles du système nerveux central, des arythmies cardiaques et de la fibrillation cardiaque.
(中) 公式(I)的新型芳香族双环胺在治疗中枢神经系统疾病、心律失常和心房颤动方面具有用途。
Dicyclic Hydrocarbons. I. 2-Aklylbiphenyls
作者:Irving A. Goodman、Paul H. Wise
DOI:10.1021/ja01163a075
日期:1950.7
Synthesis and activity of 2-methyl-3-aminopropiophenones as centrally acting muscle relaxants
Some novel 2-methyl-3-aminopropiophenones were synthesized and their centrally acting muscle relaxant activities were evaluated for an inhibitory effect on the flexor reflex in rats. The structure-activity relationships are discussed. In this series, 2-methyl-3-pyrrolidino-1-(4-trifluoromethylphenyl)-propan-1-one (28) showed significant centrally acting muscle relaxant activity. In addition, the activities of each enantiomer (28-(S) and (R)) were studied along with their acute toxicities. Compound 28-(R) was found to exhibit more potent activity and weaker acute toxicity than 28-(S). Accordingly, compound 28-(R) (NK433) is under development as a novel centrally acting muscle relaxant.
4-HYDROXY-BENZOPYRAN-2-ONES AND 4-HYDROXY-CYCLOALKYL B]PYRAN-2-ONES USEFUL TO TREAT RETROVIRAL INFECTIONS